XML 12 R4.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Unaudited Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Revenue:    
Total revenue $ 1,373 $ 1,130
Operating expenses:    
Cost of product revenues 0 137
Research and development 7,212 6,835
Selling, general and administrative 3,669 4,840
Total operating expenses 10,881 11,812
Loss from operations (9,508) (10,682)
Other (income) expense:    
Amortization of debt issuance costs and discount 401 255
Interest income (1,280) (587)
Interest expense 205 1,447
Warrant liabilities fair value adjustment (9,608) 21,673
Derivative liabilities fair value adjustment (168) 406
Total other (income) expense (10,450) 23,194
Income (loss) before taxes 942 (33,876)
Income tax expense (531) 0
Net income (loss) $ 411 $ (33,876)
Net income (loss) per share attributable to common stockholders - basic    
Net income (loss) per share - basic $ 0.01 $ (0.71)
Net income (loss) per share attributable to common stockholders - diluted    
Net income (loss) per share - diluted $ 0.01 $ (0.71)
Weighted average common shares outstanding – basic and diluted    
Basic 48,245,559 47,757,246
Diluted 48,565,051 47,757,246
Product Revenue, Net    
Revenue:    
Total revenue $ 0 $ 1,130
License Agreement Revenue    
Revenue:    
Total revenue $ 1,373 $ 0